Clinical Trial Update: Safety Study of Aqueous Suppression After Ahmed Glaucoma Valve (AGV) Implantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety of aqueous suppression after Ahmed Glaucoma Valve implantation in the hypertensive phase of glaucoma management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Snippet

Sponsor: Zahra Rabbani Khah | Conditions: Hypertensive Phase | Phase 2 | Status: UNKNOWN